@thrilltalk30
Active 3 months, 4 weeks ago
Analyses of efficacy endpoints were done for many feminine subjects and those of childbearing age (age ≥ 15 to ≤ 45 years), including subjects who became pregnant through the assessment period. Outcomes Overall, 91% (69/76) of female subjects were categorized as responders (≥ 50% lowering of HAE assaults relative to the pre-study period); 82% ex […] View